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Objective: To describe a case of bilateral acute retinal necrosis syndrome (ARNS) in a 
5-year-old boy.
Method: A retrospective, interventional case is described in one child attending the pediatric 
ophthalmology section, complaining of sudden bilateral red eye and haze-impaired vision. A 
standardized ophthalmologic examination and speciﬁ  c serological probes supported the diagnosis 
of severe bilateral ARNS in an immunocompetent child.
Results: The reduced visual acuity (20/400), the ocular fundus signs (perivasculitis, 
thrombosis and retinal edema) and the positive immunoglobulin M anti-Epstein Barr virus 
serology, lead us to the ARNS deﬁ  nitive diagnosis. Antiviral therapy (Acyclovir; Zovirax®), 
ciclopentolate dilating eye drops, and antiplatelet treatment (acetil salicylic acid; Aspirin®) were 
administered until recovering the ﬁ  nal visual acuity (20/40).
Conclusions: The ARNS is an ocular disease with poor prognosis, which in turns may display 
better course when determining the etiopathogenic virus and selecting the appropriate and 
precocious therapy.
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Introduction
Acute retinal necrosis syndrome (ARNS) was ﬁ  rstly described as Kirisawa-Urayama 
uveitis in the early seventies (Urayama et al 1971). It is a severe ocular process in 
which one or both eyes undergoes acute necrosis of the retina, leading to signiﬁ  cant 
visual loss and becoming one major source of legal blindness worldwide (Fischer et al 
1982). It has been assumed an immuno-genetic predisposition to the process, without 
racial predilection but with a higher incidence in males aged 20–55 years (Fischer 
et al 1982; Tran et al 2004).
Patients may complain of periorbital pain, hazy decreased vision, and red eye. The 
main clinical signs and symptoms are progressive retinal necrosis with occlusive retinal 
vasculitis (involving arteries and veins), focal retinitis, optic neuropathy, vitritis, and 
a high incidence of rhegmatogenous retinal detachment. The latter complicates many 
cases (up to 2/3 of all ARNS patients). Despite the usual unilateral onset, bilateral 
affection reaches 80% of the starting cases in some series (Urayama et al 1971; Fischer 
et al 1982; Tran et al 2004).
ARNS usually is the result of unknown retinal viral reactivation. Mostly the 
causal agent is the Herpesviridae familiy, mainly the varicela-zoster virus (Ganatra 
et al 2000). In adulthood is associated to infection by herpes simplex virus 1 (HSV-1) 
and the median age is 20 years, but in the case that varicella-zoster virus is involved 
the median age increases to 45–55 years. In children the ﬁ  rst etiology is the HSV-2 
(Tan et al 2001).
Although the ARNS is an ophthalmic process, it has also been described the 
association to encephalitis (Gain et al 2002; Cardine et al 2004) and dermatitis Clinical Ophthalmology 2008:2(2) 452
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(Nakanishi et al 1999). Because of this, it has to be considered 
in consultations with other specialists in the context of an 
infectious process.
Case report
A 5-year-old boy attended the ophthalmology outpatients 
care section because of a sudden conjunctival injection with 
light sensitivity associated to reduced vision (20/400) in 
both eyes. General signs were mild fever and morbilliform 
eruptions resembling viral exanthems. The initial presumptive 
diagnosis was bilateral uveitis. Fundus examination and 
photographs revealed bilateral ischaemic retina with perivas-
culitis, retinal edema, and signs of vascular thrombosis.
Based on a history of recurrent oral aphthas, the ﬁ  rst 
diagnosis was incomplete Behçet syndrome, so corticosteroid 
intravenous therapy was set. However, two days after therapy 
there was no clinical response and the boy was moved to our 
pediatric ophthalmology section for further management. 
Fundus examination revealed intense vitritis and widespread 
retinal periphlebitis (Figure 1). There was neither macular nor 
papillary affection (Figure 2). However, necrosis patches and 
focal exudation were observed in the peripheral retina. At this 
time, the presumption of an infectious etiology was estab-
lished, so treatment with intravenous acyclovir (Zovirax®) 
and acetil salicylic acid (Aspirine®) was immediately started 
and a battery of serological tests was performed in parallel. 
Ciclopentolate dilating eye drops were topically administered 
every eight hours. Four days later the positive results of the 
immunoglobulin M (IgM) anti-Epstein Barr virus (EBV) 
test were obtained, whereas the rest of serological probes 
(IgG anti-EBV, CMV, HSV, HIV, Toxoplasma, Chlamydia 
pneumoniae, and psitacci, Borrellia, Brucella, Mycoplasma, 
and Treponema) were negatives. At this time, we deﬁ  nitively 
established the ARNS diagnosis caused by EBV (see Table 1). 
The patient was conﬁ  ned to intrahospitalary regime and 
followed-up by means of funduscopic examination every 
24 hours. Ten days later IgG seroconversion for EBV was 
observed. After this, the treatment was managed as described, 
Figure 1 Retinography at the ﬁ  rst examination showing the vitreous body inﬂ  ammation and retinal periphlebitis. The initial vision was 20/400 in both eyes.Clinical Ophthalmology 2008:2(2) 453
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the clinical course improved and the patient was discharged 
from hospital with better vision (20/200 OD and 20/400 OS) 
(Figure 3). It has to be emphasized that oral acyclovir was 
recommended to this patient until posterior control appoint-
ments. Seven weeks after the admittance, the visual acuity 
was 20/40 OU and both ocular fundus appeared transparent 
with scarce pigmented scars in areas where the necrosis ﬁ  rst 
happened, lacking retinal vasculopathy or tears.
Discussion
Nowadays, ARNS is a not well-known process with a long 
lasting poor visual prognosis. The presentation in children is 
quite rare (Ganatra et al 2002; Kolackni et al 2005). In our 
case the disease bilaterally affected to a 5 year-old immuno-
competent boy, displaying the patognomonic signs and symp-
toms of the Kirisawa-Urayama uveitis, also known as the 
ARNS (Urayama et al 1971). The etiological diagnosis was 
reached by the highly suggestive ocular fundus examination, 
accompanied by the positive results of speciﬁ  c serological 
probes to the EBV (as shown in Table 1). In spite of the 
clinical diagnoses, the laboratory probes may be helpful, 
including: complete blood count, renal and liver functioning, 
viral titters for HSV 1, HSV 2, and varicella-zoster virus, and 
other complementary tests) (Knox et al 1998; Zajdenweber 
and Muccioli 2003). In some cases, image analyses can 
also help with the clinical managing of the disease, such as 
ﬂ  uorescein angiography, ultrasounds, magnetic resonance, 
etc (Zajdenweber and Muccioli 2003). These latter were not 
considered essential for managing our study case.
Basic treatment for ARNS mainly includes systemic 
antiviral therapy (acyclovir), antiinﬂ  ammatory therapy, 
antithrombotic therapy and topical cicloplegya. In this 
context, the role of corticosteroid therapy is uncertain, as 
shown in an extensive search of the literature, with opinions 
on the positive antiinﬂ  amation effects and the negative 
immunosupression ones (Blumenkranz et al 1986; Knox et al 
1998; Zajdenweber and Muccioli 2003). In addition, some 
authors have described the use of intravenous or intravitreal 
Figure 2 In detail, the retinography displays normal appearance of the macula and optic disc.Clinical Ophthalmology 2008:2(2) 454
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Table 1 Patient characteristics
Age/sex  Affected   Initial AVOD,   Initial   Inicial fundus   Diagnostic lab 
 eye  AVOI  symptoms  signs  probes
5 years Male  Both  20/400  Red eyes  Bilateral ischaemic retina  IgM anti-EBV (+)
      Light sensitivity  Perivasculitis,  IgG anti-EBV (–)
      Impaired vision  Retinal edema  CMV (–)
        Vascular thrombosis  HSV (–)
       Vitritis  HIV  (–)
        No papillary affection  Toxoplasma (–)
         Chlamydia  pneumoniae/
         psitacci  (–)
         Borrellia  (–)
         Brucella  (–)
         Mycoplasma  (–)
         Treponema(–)
Personal   Fever  Final AVOD,   Final   Final fundus   Final treatment
history   AVOI  symptoms  signs
Oral aphtas  Yes  20/40  None  Scarce pigmented scars  Intravenous acyclovir (Zovirax®)
          Acetil salicylic acid (Aspirin®)
         Ciclopentolate  eye  drops
Abbreviations: EBV, Epstein-Barr virus; IgG, immunoglobulin G; IgM, immunoglobulin M.
foscarnet (Khurana et al 2005) as well as antiplatelet agents 
associated with the acyclovir infusion (Carney et al 1986; 
Han et al 1987; Zajdenweber and Muccioli 2003; Khurana 
et al 2005). Retinal detachment prophylaxis with laser pho-
tocoagulation barricade was also recommended in cases, and 
surgery for the retinal tears (vtrectomy, endolaser, intraocular 
tamponade with silicone, octaﬂ  uoropropane/perﬂ  uoropro-
pane) has to be performed when required (Han et al 1987).
For the differential diagnoses it could be necessary to 
have mainly in mind the following processes: endophthalmi-
tis, CMV retinitis, sarcoidosis, toxoplasmosis, HIV retinitis, 
and Behçet disease.
Figure 3 Control retinography in the third week. The ﬁ  nal visual acuity was 20/200 OD and 20/400 OS.Clinical Ophthalmology 2008:2(2) 455
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We would like to emphasize that in the case presented 
herein, the highly favorable response of this boy to the 
precocious administration of antiviral treatment led us to 
avoid performing other invasive techniques, such as lumbar 
puncture (for determining cerebrospinal ﬂ  uid pleocytosis) 
and/or PCR on the aqueous humor or vitreous body, as sug-
gested by several authors in other related cases (Han et al 
1986; Tan et al 2002; Zajdenweber and Muccioli 2003; 
Kolacny et al 2005).
Standardized antiviral treatments do not commonly extend 
beyond two to three weeks. However, the uncertain prognosis 
of the long-lasting complications (bilateral involvement of 
the disease, retinal detachment, anterior ischemic optic neu-
ropathy, central retinal artery occlusion, secondary glaucoma, 
affectation of the optic pathway) strongly recommend that 
patients with this ophthalmic disease, have to strictly follow-
ing long-term treatments with oral acyclovir and attending 
the scheduled control visits. The referred complications 
go forward up to twenty years after ARNS’ ﬁ  rst signs and 
symptoms (Schlingemann et al 1996).
As the ARNS is a sight-threatening process caused by 
a rapidly progressive retinal infection, prompt treatment is 
essential for limiting viral reactivation or avoiding neuronal 
translocation that can lead to further virus spread to other 
central nervous system structures.
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